ADVFN ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Premium Iconプレミアム Help Menu
Bitcoin
63,978.31
-0.69%
S&P 500
7,420.10
-1.21%
Dow Jones
51,492.55
0.00%
US Dollar vs Yen
160.9405
0.20%
Brent Oil
78.165
-0.31%
Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC

  6. Dai Nippon Pharmaceutical (PK) (DNPUF) 銘柄情報

Dai Nippon Pharmaceutical (PK)

Dai Nippon Pharmaceutical (PK) (DNPUF)

USOTC
9.41
0.00
(0.00%)
終了 6月18日 5:00AM

Dai Nippon Pharmaceutical (PK) (DNPUF) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
9.41
( - )
買値
8.95
売値
9.95
出来高
-
0.00 日の範囲 0.00
6.34 52 週間の範囲 19.20
時価総額
4.221B
前日終値
9.41
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 9,699,639
発行済株式数
448,593,449
配当利回り
PER
5.27
1 株当たり利益 (EPS)
268.99
歳入
453.29B
純利益
106.87B

Dai Nippon Pharmaceutical (PK) について

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and p... Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. 詳細を表示

セクター
Healthcare
業界
Pharmaceuticals
ウェブサイト
www.sumitomo-pharma.com
本社
Osaka, Japan
設立
1897
Dai Nippon Pharmaceutical (PK) is listed in the Healthcare sector of the その他OTC with ticker DNPUF. The last closing price for Dai Nippon Pharmaceutical (PK) was US$9.41. Over the last year, Dai Nippon Pharmaceutical (PK) shares have traded in a share price range of US$ 6.34 to US$ 19.20.

Dai Nippon Pharmaceutical (PK) currently has 448,593,449 shares in issue. The market capitalisation of Dai Nippon Pharmaceutical (PK) is US$4.22 billion. Dai Nippon Pharmaceutical (PK) has a price to earnings ratio (PE ratio) of 5.27.

DNPUF 最新ニュース

その他のニュース
表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.5366.04011719638.8749.418.8749009.11222222CS
4-0.74-7.2906403940910.1510.158.8748439.42210682CS
12-3.665-28.030592734213.07515.228.87467011.28681145CS
26-4.95-34.470752089114.3619.28.874130113.65933659CS
522.8743.88379204896.5419.26.34119113.59904985CS
1565.04115.331807784.3719.21.9921386.29569286CS
260-10.79-53.415841584220.220.21.9920087.20193636CS

DNPUF - Frequently Asked Questions (FAQ)

What is the current Dai Nippon Pharmaceutical (PK) share price?
The current share price of Dai Nippon Pharmaceutical (PK) is US$ 9.41
How many Dai Nippon Pharmaceutical (PK) shares are in issue?
Dai Nippon Pharmaceutical (PK) has 448,593,449 shares in issue
What is the market cap of Dai Nippon Pharmaceutical (PK)?
The market capitalisation of Dai Nippon Pharmaceutical (PK) is USD 4.22B
What is the 1 year trading range for Dai Nippon Pharmaceutical (PK) share price?
Dai Nippon Pharmaceutical (PK) has traded in the range of US$ 6.34 to US$ 19.20 during the past year
What is the PE ratio of Dai Nippon Pharmaceutical (PK)?
The price to earnings ratio of Dai Nippon Pharmaceutical (PK) is 5.27
What is the cash to sales ratio of Dai Nippon Pharmaceutical (PK)?
The cash to sales ratio of Dai Nippon Pharmaceutical (PK) is 1.4
What is the registered address of Dai Nippon Pharmaceutical (PK)?
The registered address for Dai Nippon Pharmaceutical (PK) is 6-8, Doshomachi 2-chome, Osaka, 541-0045
What is the Dai Nippon Pharmaceutical (PK) website address?
The website address for Dai Nippon Pharmaceutical (PK) is www.sumitomo-pharma.com
Which industry sector does Dai Nippon Pharmaceutical (PK) operate in?
Dai Nippon Pharmaceutical (PK) operates in the Pharmaceuticals sector

DNPUF 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

議論

フィード全体を表示

最近閲覧した銘柄

USOTC
DNPUF
Dai Nippon Pharmaceutical (PK)
LSE
ZG61
Nts Lkd C260 Eq Idx-lkd ...
LSE
BV97
7.05% Nts 08/04/29
ASX
AS2
Askari Metals
EU
BE0002907880
Domestic bond 3.034% 17j...
NASDAQ
SNTI
Senti Biosciences
NASDAQ
FJCXX
Dynamic Money Market Cla...
LSE
BF73
Utd Utl Wt F36
BIT
EMLA
ETF
NYSE
BSTZ
BlackRock Science and Te...
COIN
TREEUSDT
Treehouse
USOTC
BACRP
Bank of America (PK)
LSE
57MV
Inter-am 4.50%
DBI
LZMC
DAXglobal Asia Food and ...
LSE
3SGE
Graniteshares 3xshort Al...
TG
GI4
G III Apparel
Delayed Upgrade Clock
ADVFN
日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2026 ADVFN Ltd - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す